The global diabetic footwear market size is expected to reach $8,148 million in 2023 from $4,994 million in 2016, growing at a CAGR of 7.6% from 2017 to 2023.Diabetic footwear, also known as extra depth shoes and therapeutic shoes, aim to improve & maintain the foot health of patients suffering from diabetes, who are diagnosed with foot deformities. These shoes help the patients to reduce the damage caused by skin breakdown. Diabetic footwear is designed to prevent foot injuries from frequent mobility with the help of a removable shoe insert and insole, which are made up of stretchable material for adjustability and customization.

The growth of diabetic footwear market is influenced by the rise in prevalence of diabetes, which results in increased expenditure toward the diabetes treatment, growth in population in the developing countries, and the increase in per capita income of individuals. However, lack of knowledge in terms of use of diabetic footwear and counselling for proper foot care is expected to restrain the growth of the global diabetes footwear market share.

The diabetic footwear market is segmented on the basis of type of distribution channel, end user, footwear, and geography. Based on distribution channel, it is classified into online platforms, specialty stores, footwear stores, and others. Based on end user, it is bifurcated into women and men. Online platform is expected to gain increased market share, owing to the increase in penetration in terms of internet & smartphones and the growth of the e-commerce industry. Based on footwear, the market is divided into shoes, sandals, and slippers. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, and Rest of Europe), Asia-Pacific (India, China, Japan, and Rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa). Production and availability of innovative and new diabetic shoes in the U.S. boost the growth of North America diabetes footwear market. Moreover, rise in disposable income in emerging countries, such as China and India, is expected to surge the demand for diabetic shoes in Asia-Pacific.

Key players profiled in the report include Podartis Srl (Italy), Orthofeet Inc. (U.S.), DJO Global Inc. (U.S.), Aetrex Worldwide, Inc. (U.S.), Dr. Zen Products, Inc. (U.S.), Finn Comfort (U.S.), Propet USA, Inc. (U.S.), I-Runner (U.S.), Pilgrim Shoes (U.S.), and Drew Ventures, Inc. (U.S)

KEY BENEFITS FOR STAKEHOLDERS

This study provides an in-depth analysis of the global diabetic footwear market, in terms of value, to elucidate the imminent investment pockets.
A detailed impact analysis of the current trends, regional diabetic footwear market, and future estimations are outlined to single out the profitable areas.
Key drivers, restraints, and opportunities from 2016 to 2023 is explained to identify the prevailing market opportunities.
Porter's Five Forces analysis highlights the potency of suppliers & buyers in the competitive market to facilitate efficient business planning.

By Distribution Channel

Online Platforms
Specialty Stores
Footwear Stores
Others

By Footwear

Shoe
Sandal
Slipper

By End User

Women
Men

By Geography

North America
U.S
Canada
Mexico
Europe
UK
Germany
France
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa

Key Players

Aetrex Industries, Inc. (U.S.)
New Balance Atheltics, Inc. (U.S.)
Orthofeet, Inc. (U.S.)
DJO Global, Inc. (U.S.)
Drew Shoe Corporation (U.S.)
Podartis Srl (Italy)
Propet USA, Inc. (U.S.)
Hush Puppies Retail, Inc. (U.S.)
Skechers U.S.A., Inc. (U.S.)
Dr. Zen Products, Inc. (U.S)

The other players in the value chain include (profiles not included in the report)

Finn Comfort (U.S.)
I-Runner (U.S.)
Pilgrim Shoes (U.S.)